Zhang Wenming, Li Wenbo, Bai Guochang, Huang Zida, Wu Haiyi
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2015 Apr;29(4):420-5.
To investigate the current problems and corresponding solutions regarding the use of antibiotic-impregnated cement spacer for the treatment of periprosthetic joint infection (PJI).
A retrospective analysis was made on the clinical data of 27 patients with PJI who underwent two-stage revision with antibiotic-impregnated cement spacer between January 2001 and January 2013. There were 12 males and 15 females, with an average age of 62.7 years (range, 25-81 years). All arthroplasties were unilateral, including 19 hip PJI and 8 knee PJI. The mean duration from primary arthroplasty to PJI was 25 months (range, 3-252 months). After infection was controlled with the antibiotic-impregnated cement spacer combined with systematic antibiotics treatment, two-stage revision was performed. The effectiveness was evaluated. Results One patient died of myocardial infarction at 2 days after surgery. Infection was controlled, and two-stage revision was successfully performed in 19 patients; deep venous thrombosis occurred in 1 of 3 patients who experienced hip spacer fractures, which was cured after conservative management. The spacers were removed and bacteria-sensitive antibiotics was used because of recurrent infections after the first-stage surgery in 7 patients; 3 patients gave up treatment because infection was not controlled, 4 patients received revision after infection was controlled. Twenty-three patients were followed up 1-5 years (mean, 2.3 years). The average Harris hip score and KSS score at 1 years after revision were significantly improved when compared with preoperative ones (P<0.05). In the 8 patients with gram-negative or fungus infection, 7 were found to have recurrent infection after the first-stage surgery; in the 12 patients with gram-positive infection, no recurrent infection was found. Failed treatment was observed in 1 patient with gram-positive and gram-negative infections and 2 with fungus infection, respectively.
Antibiotic- impregnated cement spacer has a satisfactory effectiveness for PJI. However, complication of spacer fracture should be noted, especially hip spacers. If the pathogen is gram-negative bacteria or fungus, the implanted spacer may increase the possibility of recurrent infection.
探讨使用抗生素骨水泥间隔物治疗人工关节周围感染(PJI)的现存问题及相应解决方法。
对2001年1月至2013年1月期间27例行两期翻修手术并使用抗生素骨水泥间隔物的PJI患者的临床资料进行回顾性分析。其中男性12例,女性15例,平均年龄62.7岁(范围25 - 81岁)。所有关节置换均为单侧,包括19例髋关节PJI和8例膝关节PJI。初次关节置换至PJI的平均病程为25个月(范围3 - 252个月)。经抗生素骨水泥间隔物联合全身抗生素治疗控制感染后,进行两期翻修手术,并评估其疗效。结果1例患者术后2天死于心肌梗死。19例患者感染得到控制,成功进行了两期翻修手术;3例髋关节间隔物骨折患者中有1例发生深静脉血栓,经保守治疗后治愈。7例患者因一期手术后反复感染取出间隔物并使用对细菌敏感的抗生素;3例患者因感染未得到控制而放弃治疗,4例患者在感染得到控制后接受翻修手术。23例患者进行了1 - 5年(平均2.3年)的随访。翻修术后1年的平均Harris髋关节评分和KSS评分与术前相比有显著改善(P<0.05)。8例革兰阴性菌或真菌感染患者中,7例在一期手术后出现反复感染;12例革兰阳性菌感染患者未发现反复感染。分别有1例革兰阳性菌和革兰阴性菌混合感染患者以及2例真菌感染患者治疗失败。
抗生素骨水泥间隔物治疗PJI疗效满意。然而,应注意间隔物骨折的并发症,尤其是髋关节间隔物。如果病原体是革兰阴性菌或真菌,植入的间隔物可能会增加反复感染的可能性。